ciprofloxacin has been researched along with genistein in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burden, DA; Elsea, SH; Lomenick, JP; Osheroff, N; Westergaard, M | 1 |
Elliott, J; Morgan, NG; Scarpello, JH | 1 |
Aylott, M; Burman, M; Harvey, J; Lynch, A; Nicholas, E; Rees, R; Siddiqui, A; Walker, S | 1 |
Guo, N; Li, L; Li, ZH; Liang, JC; Liu, G; Liu, LH; Liu, MY; Shen, FG; Wang, W; Wang, XL; Wu, XP; Xing, MX; Yu, L | 1 |
Ding, H; Jin, H; Kong, Y; Qi, C; Ruan, Z; Xie, X; Zhang, J; Zou, Y | 1 |
5 other study(ies) available for ciprofloxacin and genistein
Article | Year |
---|---|
Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugs.
Topics: Amsacrine; Animals; Anti-Infective Agents; Antineoplastic Agents; Binding Sites; CHO Cells; Ciprofloxacin; Cricetinae; DNA Topoisomerases, Type II; DNA, Superhelical; Drosophila melanogaster; Electrophoresis, Agar Gel; Enzyme Activation; Etoposide; Fluoroquinolones; Genistein; Isoflavones; Kinetics; Molecular Structure; Quinolones | 1997 |
Effects of tyrosine kinase inhibitors on cell death induced by sodium fluoride and pertussis toxin in the pancreatic beta-cell line, RINm5F.
Topics: Animals; Cell Death; Cell Line; Ciprofloxacin; DNA Fragmentation; Enzyme Inhibitors; Genistein; Islets of Langerhans; Pertussis Toxin; Protein-Tyrosine Kinases; Rats; Sodium Fluoride; Virulence Factors, Bordetella | 2001 |
Investigations into the concept of a threshold for topoisomerase inhibitor-induced clastogenicity.
Topics: Animals; Anti-Infective Agents; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Ciprofloxacin; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Genistein; Lymphoma; Mice; Mutagens; Topoisomerase I Inhibitors | 2003 |
In Vitro Synergy of Biochanin A and Ciprofloxacin against Clinical Isolates of Staphylococcus aureus.
Topics: Ciprofloxacin; Genistein; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Spectrophotometry; Staphylococcus aureus | 2011 |
Biochanin A partially restores the activity of ofloxacin and ciprofloxacin against topoisomerase IV mutation-associated fluoroquinolone-resistant Ureaplasma species.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Genistein; Humans; Male; Microbial Sensitivity Tests; Ofloxacin; Phytoalexins; Sesquiterpenes; Ureaplasma | 2017 |